US-based Cancer Genetics acquires Ventureast-backed BioServe India
US-based Cancer Genetics Inc (CGI), a NASDAQ-listed company that provides DNA-based diagnostics, has acquired Hyderabad-based BioServe Biotechnologies (India) Pvt Ltd, providing genomic and molecular services, for around $1.9 million in an all-stock transaction. “With BioServe, CGI will become better positioned to increase our global presence in personalised cancer care and further improve outcomes and lower costs for cancer patients,” said Panna Sharma, CEO of Cancer Genetics.
...